Pleasanton, United States
Apostle Inc, founded in 2017 and headquartered in the United States, is a promising player in the rapidly evolving fields of Biopharma, Biotechnology, Health Care, and Medical Devices. The company's slogan, "Apostle is a provider of innovative technologies and services for public health and life sciences," underscores its focus on advancing public health through cutting-edge science.
The company specializes in cell-free DNA technologies applied in liquid biopsies, a nascent yet potential-rich avenue promising breakthroughs in early cancer detection, cancer monitoring, and non-invasive prenatal tests. Having been recognized among BioSpace's Top 20 Life Science Startups to watch in 2018 and acknowledged as a Stanford University StartX company, Apostle has garnered impressive early achievements.
Recent financial milestones include a $3.33M Series A investment in May 2019 from notable investors such as Amino Capital, StartX, ShangBay Capital, and Aethan Capital, reflecting solid confidence in its technological promise and growth potential.
